OTC Pharmaceuticals - Canada

Canada

Revenue in the OTC Pharmaceuticals market amounts to €3,380.00m in 2024. The market is expected to grow annually by 4.31% (CAGR 2024-2029).
The market's largest segment is the segment Vitamins & Minerals with a market volume of €918.40m in 2024.
In global comparison, most revenue is generated in the United States (€38,250m in 2024).
In relation to total population figures, per person revenues of €86.44 are generated in 2024.
In the OTC Pharmaceuticals market, 31.6% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The OTC Pharmaceuticals market in Canada has experienced significant growth in recent years, driven by several key factors.

Customer preferences: Canadian consumers have shown a growing preference for self-care and self-medication, which has contributed to the increasing demand for OTC pharmaceuticals. This trend is driven by several factors, including convenience, cost-effectiveness, and a desire for greater control over their own healthcare. Additionally, the aging population in Canada has also played a role in driving the demand for OTC pharmaceuticals, as older adults often require medications for chronic conditions that can be managed with over-the-counter products.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in Canada is the increasing availability and variety of products. Canadian consumers have access to a wide range of OTC medications, including pain relievers, cough and cold remedies, digestive aids, and allergy medications. This variety allows consumers to choose products that best meet their individual needs and preferences. Another trend in the market is the growing popularity of natural and herbal remedies. Many consumers are seeking alternatives to traditional pharmaceuticals and are turning to natural products for their healthcare needs.

Local special circumstances: One of the unique aspects of the OTC Pharmaceuticals market in Canada is the role of the government in regulating these products. Health Canada, the country's regulatory agency, is responsible for ensuring the safety and efficacy of OTC medications. This includes reviewing and approving new products, monitoring adverse events, and providing guidance to manufacturers and consumers. The strict regulations in place help to ensure that Canadian consumers have access to safe and effective OTC medications.

Underlying macroeconomic factors: Several macroeconomic factors have contributed to the growth of the OTC Pharmaceuticals market in Canada. The country's strong economy and high disposable income levels have allowed consumers to spend more on healthcare products, including OTC medications. Additionally, the increasing prevalence of chronic diseases, such as diabetes and cardiovascular disease, has also driven the demand for OTC pharmaceuticals. As these conditions become more common, consumers are seeking products that can help them manage their symptoms and improve their quality of life. In conclusion, the OTC Pharmaceuticals market in Canada has experienced significant growth in recent years, driven by factors such as customer preferences for self-care, the availability of a wide range of products, and the role of the government in regulating these products. The market is expected to continue to grow as Canadian consumers increasingly seek out OTC medications for their healthcare needs.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.